Viewing Study NCT05283135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-01-25 @ 11:31 PM
Study NCT ID: NCT05283135
Status: COMPLETED
Last Update Posted: 2025-10-24
First Post: 2022-02-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: High Dose Risankizumab for Psoriasis
Sponsor: Oregon Medical Research Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None Risankizumab View
None Plaque View
None Skyrizi View